Merging

&

Pharma Biotech

Bi

PHARMACEUTiQUES

Pipeline expansion, renewed interest from big pharma in forging multiple alliances with biotech companies, IPO preparations… at a time when biotech is bubbling again and with the frontier between pharma and biotech becoming increasing blurred, Pharmaceutiques offers you the opportunity to capitalize on its experience via a new publication – BioPharmaceutiques. BioPharmaceutiques offers you access to the latest biotech information with a resolutely European angle and interprets the sector’s news from a pharma perspective. Every week, BioPharmaceutiques delivers high-quality content to your e-mail inbox: -

biotech-biotech and pharma-biotech alliances and M&A activity the latest IPOs the latest milestones and investment rounds an overview of the most recent biotech start-ups clinical trial launches the latest developments in the field of biotech drugs news on European directives and regulations a "movers and shakers" section, with the latest appointments

Rather than being just another weekly newsletter, BioPharmaceutiques also seeks to provide sector stakeholders (the pharma industry, biotech companies, CROs, investors, funding bodies and institutional players) with a rapidly assimilated summary of who is doing what and with whom. Thanks to a dedicated website with weekly updates from the latest editions of BioPharmaceutiques, subscribers will have access to summary tables providing molecule, company and disease-specific overviews of the latest negotiations, alliances and developments.

OUR WEEKLY NEWSLETTER Biotech news at a glance

•

Delivered weekly to your inbox, Bi Pharmaceutiques focuses in on the latest biotech news. Your time is precious, so you need a tool which can identify the sector's key information - Bi Pharmaceutiques gives you immediate access to a list of article headlines

•

If something catches your eye and you want to find out more, just click on the title's hyperlink and access the full content.

DRILLING DOWN: OUR INTERACTIVE SUMMARY TABLES "WHO IS DOING WHAT AND WITH WHOM IN THE EUROPEAN BIOTECH SECTOR?" Based on a template enabling you to sort information by company, development phase, compound or disease. Our summary tables enable you to answer these key questions and access synoptic data.

Featured summary tables: Agreements Clinical Studies Fundraisings Acquisitions

A subscription format which is clear and straightforward just like the concept behind Bi Pharmaceutiques

•

A single corporate subscription for your whole company Offer all your employees access to Bi Pharmaceutiques with no restrictions on numbers and in full compliance with intellectual property rules. When subscribing, just send us a list of your company's subscriber names. As soon as your subscription has been processed, you will automatically receive the Bi Pharmaceutiques newsletter. To access the content and resources on the Bi Pharmaceutiques website, you will have to activate your account during your first visit.

•

•

•

SUBSCRIPTION RATES FOR 2007 Pharmaceutical companies: €3,000 + VAT per annum Biotech companies with a turnover > €20 million: €3,000 + VAT per annum Biotech companies with a turnover < €20 million and other subscribers:

september 2007

€1,000 + VAT per annum

Bi

PHARMACEUTiQUES BioPharmaceutiques Publisher: PR Editions 22, avenue d’Eylau, F-75116 Paris, France Subscriptions: +33 144 058 300 [email protected] www.biopharmaceutiques.com

SUBSCRIPTION FORM

Bi

PHARMACEUTiQUES

Your tariff: ❑ ❑ ❑ ❑

Pharmaceutical companies: €3,000 + VAT per annum Biotech companies (turnover > €20 million): €3,000 + VAT per annum Biotech companies (turnover < €20 million): €1,000 + VAT per annum Other category, please specify: . . . . . . . . . . €1,000 + VAT per annum

This corporate subscription enables you to provide all your employees with access to the Bi Pharmaceutiques newsletter. On receipt of this document, we will contact you in order to define the distribution mode.

•

Subscription manager: Family name: . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . First name: . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Company/organization: . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Job title: . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Street address: . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Town/city: . . . . . . . . . . . . . . . . . . . . . . . . . . . Postcode/zip code: . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . State (if applicable): . . . . . . . . . . . . . . . . . . Country: . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Tel.: . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . E-mail: . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

Billing address: Company/organization: . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Department: . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Contact person: . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Street address: . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Town/city: . . . . . . . . . . . . . . . . . . . . . . . . . . . Postcode/zip code: . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . State (if applicable): . . . . . . . . . . . . . . . . . . Country: . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

Signature

Date

Subscription information: Pharmaceutiques magazine Tel.: +33 144 058 302 – Fax: +33 144 058 318 [email protected] www.biopharmaceutiques.com Postal/mailing address: Pharmaceutiques / Service Abonnements - 22 avenue d’Eylau - F-75116 Paris, France